These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6092671)

  • 1. The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation.
    Mes-Masson AM; Schaffhausen B; Hassell JA
    J Virol; 1984 Nov; 52(2):457-64. PubMed ID: 6092671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis.
    Oostra BA; Harvey R; Ely BK; Markham AF; Smith AE
    Nature; 1983 Aug 4-10; 304(5925):456-9. PubMed ID: 6308461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyoma viral middle T-antigen is required for transformation.
    Mes AM; Hassell JA
    J Virol; 1982 May; 42(2):621-9. PubMed ID: 6283174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino terminus of polyomavirus middle T antigen is required for transformation.
    Cook DN; Hassell JA
    J Virol; 1990 May; 64(5):1879-87. PubMed ID: 2157858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of polyomavirus large-T-antigen proteins expressed by mutant genes.
    Nilsson SV; Magnusson G
    J Virol; 1984 Sep; 51(3):768-75. PubMed ID: 6088799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.
    Markland W; Oostra BA; Harvey R; Markham AF; Colledge WH; Smith AE
    J Virol; 1986 Aug; 59(2):384-91. PubMed ID: 2426465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and biochemical analysis of transformation-competent, replication-defective simian virus 40 large T antigen mutants.
    Manos MM; Gluzman Y
    J Virol; 1985 Jan; 53(1):120-7. PubMed ID: 2981330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.
    Cheng SH; Markland W; Markham AF; Smith AE
    EMBO J; 1986 Feb; 5(2):325-34. PubMed ID: 3011402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual transforming activity of PY1178T, a mutant lacking the principal in vitro tyrosine phosphorylation site, is not affected by removal of the secondary tyrosine phosphorylation site at residue 322.
    Schaffhausen BS; Liang TJ; Carmichael GG; Benjamin TL
    Virology; 1985 Jun; 143(2):671-5. PubMed ID: 2998034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen.
    Markland W; Cheng SH; Oostra BA; Smith AE
    J Virol; 1986 Jul; 59(1):82-9. PubMed ID: 2423706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simian virus 40 large T-antigen point mutants that are defective in viral DNA replication but competent in oncogenic transformation.
    Manos MM; Gluzman Y
    Mol Cell Biol; 1984 Jun; 4(6):1125-33. PubMed ID: 6330530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal amino acid sequences of the polyoma middle-size T antigen are important for protein kinase activity and cell transformation.
    Templeton D; Eckhart W
    Mol Cell Biol; 1984 May; 4(5):817-21. PubMed ID: 6328268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of the amino-terminal half of polyomavirus middle-T antigen indicates that this region is the binding domain for pp60c-src.
    Markland W; Smith AE
    J Virol; 1987 Feb; 61(2):285-92. PubMed ID: 2433463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen.
    Carmichael G; Schaffhausen BS; Mandel G; Liang TJ; Benjamin TL
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):679-83. PubMed ID: 6322163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector.
    Davidson D; Hassell JA
    J Virol; 1987 Apr; 61(4):1226-39. PubMed ID: 3029418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for the C-terminal region of middle T-antigen in cellular transformation by polyoma virus.
    Novak U; Griffin BE
    Nucleic Acids Res; 1981 May; 9(9):2055-73. PubMed ID: 6272223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antibody to a synthetic peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine phosphorylation sites.
    Harvey R; Oostra BA; Belsham GJ; Gillett P; Smith AE
    Mol Cell Biol; 1984 Jul; 4(7):1334-42. PubMed ID: 6095063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of viable mutants of polyomavirus cold sensitive for maintenance of cell transformation.
    Templeton D; Eckhart W
    J Virol; 1984 Mar; 49(3):799-805. PubMed ID: 6321764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 61,000-dalton truncated large T-antigen is uniformly expressed in hamster cells transformed by polyomavirus.
    Rey-Bellet V; Türler H
    J Virol; 1984 May; 50(2):587-97. PubMed ID: 6323758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role?
    Dalianis T; Ramqvist T; Klein G
    Int J Cancer; 1984 Sep; 34(3):403-6. PubMed ID: 6090322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.